Talphera (TLPH) Enterprise Value (2011 - 2026)
Talphera (TLPH) posted Enterprise Value of $44.4 million for Q2 2026, up 217.63% on a QoQ basis from $14.0 million in Q1 2026, and up 388.1% year-over-year from $9.1 million in Q2 2025.
Analysis
Talphera (TLPH) Enterprise Value (2011 - 2026) Analysis & Trends
Talphera has reported Enterprise Value for 16 years, with the latest figure at $44.4 million in Q2 2026.
- On a quarterly basis, Enterprise Value rose 388.1% year-over-year to $44.4 million in Q2 2026; TTM through Jun 2026 was $44.4 million, a 388.1% increase from a year earlier, with the FY2025 full-year figure at $21.4 million, up 366.84% from the prior year.
- Enterprise Value was $44.4 million for Q2 2026 at Talphera, up from $14.0 million in the prior quarter.
- The five-year high for Enterprise Value was $44.4 million in Q2 2026, with the low at -$14.2 million in Q1 2022.
- Average Enterprise Value over 5 years is $5.6 million, with a median of $4.7 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value sank 168.67% in 2023, then surged 1754.81% in 2025.
- Over 5 years, Enterprise Value stood at -$7.1 million in 2022, then soared by 93.05% to -$496357.8 in 2023, then surged by 1022.06% to $4.6 million in 2024, then jumped by 366.84% to $21.4 million in 2025, then jumped by 107.73% to $44.4 million in 2026.
- The last three Enterprise Value figures came in at $44.4 million (Q2 2026), $14.0 million (Q1 2026), and $21.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.38 Mn |
| Mar 31, 2026 | 13.97 Mn |
| Dec 31, 2025 | 21.37 Mn |
| Sep 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 9.09 Mn |
| Mar 31, 2025 | 7.75 Mn |
| Dec 31, 2024 | 4.58 Mn |
| Sep 30, 2024 | 11.43 Mn |
| Jun 30, 2024 | 8.70 Mn |
| Mar 31, 2024 | 417,622.21 |
| Dec 31, 2023 | -496,357.78 |
| Sep 30, 2023 | -3.56 Mn |
| Jun 30, 2023 | 4.79 Mn |
| Mar 31, 2023 | -6.14 Mn |
| Dec 31, 2022 | -7.14 Mn |
| Sep 30, 2022 | 5.18 Mn |
| Jun 30, 2022 | -321,328.19 |
| Mar 31, 2022 | -14.21 Mn |
| Dec 31, 2021 | -13.98 Mn |
| Sep 30, 2021 | 78.00 Mn |